Eversheds Ireland plays key role in the takeover of Paladin Labs by Endo Health
Eversheds Ireland has played a key role in the takeover by Endo Health Solutions of Paladin Labs Europe for approximately £1.1bn.
In this transaction, the acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target.
An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
It is not known what a vote either way might ultimately mean for employers with operations in Scotland or those who trade with Scottish businesses.
The final Allocation Framework for the distribution of CfD contracts was published by DECC on 1 September 2014.
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe